Risk factors for brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, radiotherapy and chemotherapy
Author(s) -
Marina Petrović,
Nevenka Ilić,
Olivera Lončarević,
Ivan Čekerevac,
Zorica Lazić,
Ljiljaovković,
Vojislav Ćupurdija,
Gordana Kostić
Publication year - 2011
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp1108643p
Subject(s) - medicine , radiation therapy , lung cancer , chemotherapy , brain metastasis , stage (stratigraphy) , oncology , etoposide , taxane , cancer , surgery , metastasis , breast cancer , paleontology , biology
Lung cancer is a leading cause of mortality among patients with carcinomas. The aim of this study was to point out risk factors for brain metastases (BM) appearance in patients with IIIA (N2) stage of nonsmall cell lung cancer (NSCLC) treated with three-modal therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom